Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular Endocrinology

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2003-0154PMID 12819299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 32-Kilodalton Subunit of Replication Protein A Interacts with Menin, the Product of the MEN1 Tumor Suppressor Gene

  2003influential reference
• Pancreatic-Cell-specific Ablation of the Multiple Endocrine Neoplasia Type 1 ( MEN 1 ) Gene Causes Full Penetrance of Insulinoma Development in Mice 1

  2003cited by this paper
• Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.

  2003cited by this paper
• Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.

  2003influential reference
• Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation.

  2002cited by this paper
• Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.

  2002cited by this paper
• MEN1 tumor‐suppressor protein localizes to telomeres during meiosis

  2002cited by this paper
• Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein

  2002cited by this paper
• The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation

  2001cited by this paper
• The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation.

  2001cited by this paper
• A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

  2001influential reference
• Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.

  2001cited by this paper
• Menin interacts directly with the homeobox-containing protein Pem.

  2001cited by this paper
• Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling

  2001cited by this paper
• Multiple endocrine neoplasia type 1: new clinical and basic findings.

  2001cited by this paper
• Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues

  2000cited by this paper
• Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene

  1999cited by this paper
• Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

  1999cited by this paper
• Multiple endocrine neoplasia type 1.

  1999cited by this paper
• Characterization of the mouse Men1 gene and its expression during development

  1998cited by this paper
• Characterization of mutations in patients with multiple endocrine neoplasia type 1.

  1998cited by this paper
• Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.

  1998cited by this paper
• Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.

  1997cited by this paper
• Positional cloning of the gene for multiple endocrine neoplasia-type 1.

  1997cited by this paper
• Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.

  1997cited by this paper
• Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.

  1997influential reference
• Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

  1997cited by this paper
• Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients.

  1996cited by this paper
• Allelotyping of follicular thyroid tumors

  1995cited by this paper
• Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.

  1991cited by this paper
• Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.

  1990cited by this paper
• Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

  1990cited by this paper
• Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma

  1988cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Alterations of the MEN1 Gene in Sporadic

  year unknowncited by this paper

• Approach to the Patient with Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1.

  2025cites this paper
• Heterozygous Men1(+/T) Knockout Mice Do Not Develop Bronchopulmonary Neuroendocrine Hyperplasia or Neoplasia but Bronchial Adenocarcinoma

  2025influential citation
• Hsp70 incompletely disaggregates misfolded K488X-menin to promote tumourigenesis in a family with multiple endocrine neoplasia type 1.

  2025cites this paper
• Menin in Cancer

  2024influential citation
• Pancreatic GHRHomas in Patients with or without Multiple Endocrine Neoplasia Type 1 (MEN 1) : An Analysis of 36 Reported Cases.

  2024cites this paper
• Alternative splicing generates isoform diversity in MEN1

  2024cites this paper
• Генетический профиль образований околощитовидных желез: приоткрывая завесу тайны

  2024cites this paper
• NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations

  2024cites this paper
• Menin signaling and therapeutic targeting in breast cancer.

  2024cites this paper
• Molecular alterations and therapeutic targets in pancreatic neuroendocrine tumors

  2023cites this paper
• Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions

  2023cites this paper
• Molecular and Clinical Spectrum of Primary Hyperparathyroidism.

  2023cites this paper
• MEN1 degradation induced by neddylation and the CUL4B-DCAF7 axis promotes pancreatic neuroendocrine tumor progression.

  2023cites this paper
• MENIN‐mediated regulation of gastrin gene expression and its role in gastrinoma development

  2023cites this paper
• Blood-based proteomic signatures associated with MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.

  2023cites this paper
• Menin orchestrates hepatic glucose and fatty acid uptake via deploying the cellular translocation of SIRT1 and PPARγ

  2023influential citation
• Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.

  2022cites this paper
• Preclinical Models of Neuroendocrine Neoplasia

  2022cites this paper
• Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects

  2022cites this paper
• MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells.

  2022cites this paper
• An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms.

  2022cites this paper
• Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival

  2022cites this paper
• Néoplasie endocrinienne multiple de type 1

  2022cites this paper
• Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms

  2021cites this paper
• Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets

  2021cites this paper
• Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes

  2021cites this paper
• Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1

  2021cites this paper
• Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice

  2020influential citation
• Involvement of the MEN1 Gene in Hormone-Related Cancers: Clues from Molecular Studies, Mouse Models, and Patient Investigations

  2020cites this paper
• Multiple Endocrine Neoplasia Type 1: Latest Insights.

  2020cites this paper
• Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions

  2020cites this paper
• Chloroquine induces apoptosis in PanNEN via endoplasmic reticulum stress.

  2020cites this paper
• c-MET Inhibition: Novel Treatment for Sporadic and MEN1-associated GEP NET.

  2020cites this paper
• Molecular basis of parathyroid hormone overexpression

  2020cites this paper
• Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations

  2020cites this paper
• Genetic background influences tumour development in heterozygous Men1 knockout mice

  2020cites this paper
• New and future perspectives for parathyroid carcinoma.

  2020cites this paper
• Molecular genetic insights into sporadic primary hyperparathyroidism.

  2019cites this paper
• Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)

  2019cites this paper
• Molecular Mechanisms of Carcinogenesis Associated with MEN1 Gene Mutation

  2019cites this paper
• Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors.

  2019cites this paper
• A somatic mutation in MEN1 gene detected in periventricular nodular heterotopia tissue obtained from depth electrodes

  2019cites this paper
• Generation and characterization of Men1 mutant mouse models for studying MEN1 disease

  2019cites this paper
• GLP-1 signaling suppresses menin’s transcriptional block by phosphorylation in β cells

  2019cites this paper
• Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models

  2018cites this paper
• Apatinib inhibits tumor growth and angiogenesis in PNET models

  2018cites this paper
• Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches.

  2018cites this paper
• MiR‐24‐3p regulates cell proliferation and milk protein synthesis of mammary epithelial cells through menin in dairy cows

  2018cites this paper
• Ovarian Cancer and the Environment: Rodent Models

  2018cites this paper
• Current and emerging therapies for PNETs in patients with or without MEN1

  2018cites this paper
• Functional Defects From Endocrine Disease–Associated Mutations in HLXB9 and Its Interacting Partner, NONO

  2018cites this paper
• Pituitary somatolactotropes evade an oncogenic response to Ras.

  2018cites this paper
• Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model

  2018cites this paper
• Molecular Genetics of MEN1-Related Neuroendocrine Tumors

  2017cites this paper
• A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control

  2017cites this paper
• Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific.

  2017cites this paper
• The future: genetics advances in MEN1 therapeutic approaches and management strategies.

  2017cites this paper
• Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification.

  2017cites this paper
• MENIN loss as a tissue-specific driver of tumorigenesis.

  2017cites this paper
• Translational research in neuroendocrine tumors: pitfalls and opportunities

  2017cites this paper
• Evaluation of a novel mouse model of pancreatic neuroendocrine tumors

  2017influential citation
• Chapter 16 – Prolactinoma

  2017cites this paper
• Genetics of Pituitary Adenoma

  2017cites this paper
• Animal models of MEN1.

  2017cites this paper
• Animal models of spontaneous pancreatic neuroendocrine tumors.

  2016cites this paper
• Mouse models of adrenocortical tumors.

  2016cites this paper
• Animal models of multiple endocrine neoplasia.

  2016cites this paper
• Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.

  2016cites this paper
• Histopathological changes induced by selective inactivation of menin on the thyroid gland in RET÷PTC3 and E7 transgenic mice. A study of 77 cases.

  2016cites this paper
• Animal models of pituitary neoplasia

  2016cites this paper
• GATA factors in endocrine neoplasia.

  2016cites this paper
• Chapter 148 – Multiple Endocrine Neoplasia Type 1

  2016cites this paper
• Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.

  2015cites this paper
• Islet Cells Serve as Cells of Origin of Pancreatic Gastrin-Positive Endocrine Tumors

  2015cites this paper
• Genetic mutations in sporadic pituitary adenomas—what to screen for?

  2015cites this paper
• Familial syndromes associated with neuroendocrine tumours

  2015cites this paper
• Insulinoma: Literature’s Review (Part 1)

  2015cites this paper
• Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b)*

  2015cites this paper
• The Multiple Endocrine Neoplasia Syndromes

  2015cites this paper
• Roles of HLXB9 in insulinoma cells

  2015cites this paper
• The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth

  2015cites this paper
• Molecular Pathology of Pancreatic Neuroendocrine Neoplasms

  2015cites this paper
• Familial pituitary tumors.

  2014cites this paper
• Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma

  2014cites this paper
• MEN1-tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2

  2014cites this paper
• Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation

  2014cites this paper
• The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis

  2014cites this paper
• Animal Models of Adrenal Genetic Disorders

  2014cites this paper
• Gastroenteropancreatic endocrine tumors.

  2014cites this paper
• Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

  2014cites this paper
• Osteoblast Menin Regulates Bone Mass in Vivo*

  2014cites this paper
• The role of genetic and epigenetic changes in pituitary tumorigenesis.

  2014cites this paper
• Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies.

  2014cites this paper
• Genetically Engineered Mouse Models of Pituitary Tumors

  2014cites this paper
• p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?

  2014cites this paper
• Challenges and opportunities in targeting the menin-MLL interaction.

  2014cites this paper
• Animal models and cell lines of pancreatic neuroendocrine tumors.

  2013cites this paper
• Familial Pituitary Adenomas

  2013cites this paper
• The many facets of MLL1 regulation

  2013cites this paper
• Characterization of Drosophila Menin Protein Interactions and a Potential Role for Menin in the Insulin Signalling Pathway

  2013cites this paper